Definitions
from The American Heritage® Dictionary of the English Language, 5th Edition.
- noun The branch of biology that deals with the structure and function of glycans.
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun biochemistry The study of the
biological role ofcarbohydrates (especiallyoligosaccharides ) andglycosides
Etymologies
from Wiktionary, Creative Commons Attribution/Share-Alike License
Support
Help support Wordnik (and make this page ad-free) by adopting the word glycobiology.
Examples
-
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that the U.S. Patent and Trademark Office has issued two patents covering the company's lead drug candidate and related compounds.
MP3Board.com 2010
-
"A major focus of my research has been the development of chemical approaches for probing the functions of glycans in cell-based systems, and the application of these tools to studies of glycobiology."
-
"As the pioneer of nutritional glycobiology and supporter of athletics globally, we will continue to be a leader in the field of validated sports nutrition."
-
"A major focus of my research has been the development of chemical approaches for probing the functions of glycans in cell-based systems, and the application of these tools to studies of glycobiology."
THE MEDICAL NEWS 2010
-
For the past decade, Bertozzi, a leading authority on glycobiology, has worked with various collaborators to devise means by which glycans can be used for molecular imaging in living cells and organisms.
-
Experience in glycobiology/glycomics is desirable but not essential.
-
"As the pioneer of nutritional glycobiology and supporter of athletics globally, we will continue to be a leader in the field of validated sports nutrition."
-
For the past decade, Bertozzi, a leading authority on glycobiology, has worked with various collaborators to devise means by which glycans can be used for molecular imaging in living cells and organisms.
THE MEDICAL NEWS 2010
-
Privately held GlycoMimetics, which is developing a new class of glycobiology-based therapies for a broad range of indications, raised $38 million in its latest round of venture financing.
-
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two abstracts describing preclinical studies with GMI-1070 have been selected for oral presentations at the 51st Annual American Society of
THE MEDICAL NEWS 2009
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.